[Federal Register Volume 80, Number 164 (Tuesday, August 25, 2015)]
[Notices]
[Page 51606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21014]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Pistoia Alliance, Inc.

    Notice is hereby given that, on July 15, 2015, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Pistoia Alliance, Inc. has filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, DNAnexus, Mountain 
View, CA; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of 
Takeda Pharmaceutical Company Limited, Cambridge, MA; Tessella, 
Abingdon, UNITED KINGDOM; and Vermillion Life Sciences Ltd., 
Colleyland, UNITED KINGDOM, have been added as parties to this venture.
    Also, Etzard Stotle (individual member), Arlesheim, SWITZERLAND, 
has withdrawn as a party to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Pistoia Alliance, Inc. intends to 
file additional written notifications disclosing all changes in 
membership.
    On May 28, 2009, Pistoia Alliance, Inc. filed its original 
notification pursuant to Section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to Section 
6(b) of the Act on July 15, 2009 (74 FR 34364).
    The last notification was filed with the Department on April 29, 
2015. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on June 4, 2015 (80 FR 31920).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2015-21014 Filed 8-24-15; 8:45 am]
 BILLING CODE P